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Abstract
Aim: To evaluate the relationship between serum antibodies against ox-LDL levels and adult acute myeloblastic
leukemia (AML).
Methods: Forty three patients with AML and 52 normal controls were enrolled in this study in the Department of
Hematology, Tumor Center of Qilu Hospital of Shandong University from Feb. 2008 to Mar.2009. Serum lgG and
lgM antibodies versus the oxLDL levels were evaluated by ELISA method. Data was analyzed by covariance and
binary Logistic regression.
Results: Serum mean levels of oxLDL-lgG in patients (38.92 ± 21.1259 ug/ml) were significantly lower than in
control subjects (78.88 ± 9.3705 ug/ml); Meanwhile, Serum mean levels of oxLDL-lgM in patients (20.53 ± 10.2990
IU/L) were significantly higher than in control subjects (10.29 ± 10.5771 IU/L). Binary logistic regression showed the
odds ratios of association of oxLD-lgG and oxLD-lgM with adult AML were 0.72(95%CI: 0.55-0.94) and 1.11(95%CI:
1.01-1.21) respectively after adjusted for potential confounders.
Conclusion: In the preliminary investigation we found a descensive oxLDL- lgG and an elevated oxLDL-lgM serum
levels for the adult AML. Future studies need to confirm the hypothesis whether they related to the development
and progression of adult AML.
Background
More than two decades ago, epidemiological studies
showed a U-shaped relationship between total choles-
terol (TC) levels and risk of all-cause mortality. The
relationship between the baseline serum cholesterol
level to total mortality was attributed to the high num-
ber of deaths associated with serum cholesterol level at
the high end of the distribution (mainly due to coronary
heart disease) and at the low end (mainly due to cancer)
[1-3].
Recent studies showed that, as an endocrine organ,
adipose tissue plays an important role in regulating
energy metabolism and inflammation. It has also been
associated with several cancers. Some studies have
shown that adiponectin (ADP), Serum immunoglobulin
G and immunoglobulin M antibodies versus the oxLDL
levels (oxLDL-lgG, oxLDL-lgM) may play a role in the
development and progression of various types of malig-
nancies [4-6].
Moreover, there is no single published study with
i n f o r m a t i o no nt h es e r u ml e v e l so fo x L D L - l g Ga n d
oxLDL-lgM for the patients with adult acute myeloblas-
tic leukemia (AML). We made a primary study to evalu-
ate the association of oxLD-lgG or oxLD-lgM with adult
AML.
Methods
Study subjects
The present study covers 43 adult (17-70 years old)
AML cases whose first diagnosis was performed based
on clinical, laboratory, and blood smears of their bone
marrow punctured in the Department of Hematology,
Tumor Center of Qilu Hospital between February 2008
and March 2009.
Fifty-two controls were selected from a community
screening examination of health care during the same
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any medium, provided the original work is properly cited.period in the city. Patients with liver diseases, diabetes,
or cardiovascular diseases including coronary heart dis-
ease, angina pectoris, myocardial infarction, cardiac
arrhythmia, heart failure diagnosed via general medical
check, electrocardiogram, and abdomen supersonic
inspection were excluded from the study. Informed con-
sent was obtained from all the subjects. The study pro-
tocol was approved by the local ethics committee.
Measurements
A survey of the characteristics of the subjects such as
name, gender, age, occupation, and so on was conducted
using a questionnaire. Blood pressure was measured by
a mercury sphygmomanometer. Hypertension was
defined as medication dependent or systolic blood pres-
sure (SBP) ≥140 mmHg and/or diastolic blood pressure
(DBP) ≥90 mmHg.
Blood sampling and biochemical analysis
Venous blood samples were taken from the study parti-
cipants the morning after an overnight fast of at least 12
h. Plasma and serum were separated. The specimens
were then kept frozen at -40°C until assayed. High-den-
sity lipoprotein-cholesterol (HDL-c), TC, and triglycer-
ide (TG) levels were determined by enzymatic
techniques. LDL-c was calculated by the Friedewald for-
mula (LDL-c = TC - HDL-c - TG/5). Serum albumin
was determined by the bromocresol green method.
Determination of serum oxLDL, oxLDL-lgG, and oxLDL-
lgM
An enzyme-linked immunosorbant assay (ELISA) for
oxLDL, oxLDL-lgG, and oxLDL-lgM were performed
with oxLDL, oxLDL-lgG, and oxLDL-lgM ELISA kits
purchased from the Adliteram Diagnostic Laboratories,
Inc., USA. According to the manufacturer’si n s t r u c -
tions, using coated microtitration strips of 96-well
plates, plasma was diluted 1:1, and incubated at room
temperature for 1 h in plates precoated with oxLDL,
oxLDL-lgG, or oxLDL-lgM, respectively. After three
washings, the plates were incubated with horseradish
peroxidase (HRP) at room temperature for 30 minutes.
After the removal of unbound conjugates by washing
the samples three times, tetramethylbenzidine (TMB)
was added to the wells as a chromogenic substrate.
The mixture was incubated at room temperature in
the dark for 10 minutes. Color development was
stopped via a stopping solution, and absorbency was
measured at 450 nm within 30 minutes. The oxLDL,
oxLDL-lgG, and oxLDL-lgM titers were calculated by
constructing a standard curve using the standards
included in the kits. The oxLDL, oxLDL-lgG, and
oxLDL-lgM concentrations in the samples were quan-
tified in biomedical units as defined by the manufac-
turer. The intra-assay and inter-assay reproducibility
(coefficients of variation) of the assay were 5%, 7%,
and 10%, respectively.
Statistical analysis
All statistical analyses were performed using SPSS15.0.
The baseline characteristics were presented for quantita-
tive data as mean ± standard deviation (SD), which
compares the two groups with the Student’s t test. Qua-
litative data were tested using the chi-square test. Corre-
lations between variables were tested by Kendall’s
correlation test depending on the data distribution. Ana-
lysis of covariance (ANCOVA) was used to compare the
oxLDL-lgG and oxLDL-lgM concentrations among two
groups that control the influence of covariates. Binary
logistic regression was applied to analyze the influencing
factors. Probability was significant at a level of ≤0.05.
Results
Characteristics of subjects
Table 1 shows the clinical and biochemical characteris-
tics of the studied population. No significant differences
were observed for gender distribution, SBP, TG, and
OXLDL. However, age, DBP, albumin, ADP, TC, HDL-
c, LDL-c, oxLDL-lgG, and oxLDL-lgM were significantly
different between the two groups.
Comparison of oxLDL-lgG and oxLDL-lgM between two
groups
Univariate analyses showed that plasma oxLDL-lgG cor-
related positively with age, DBP, TC, HDL-c, LDL-c,
and oxLDL-lgM, but correlated negatively with TG. It
showed no correlation to gender, SBP, albumin, HDL-c,
and oxLDL. (Table 2). Meanwhile, plasma oxLDL-lgM
correlated positively with ADP and negatively with age,
DBP, TC, HDL-c, LDL-c, and oxLDL-lgG. It showed no
correlation with sex, SBP, albumin, TG, and oxLDL.
As shown in Table 3 the oxLDL-lgG and oxLDL-lgM
levels were significantly different between the two
groups in ANCOVA models, which included the covar-
iance variables of age, sex, SBP, DBP, albumin, LDL-c,
HDL-c, oxLDL, ADP, TC, TG, and oxLDL-lgM in the
model respectively.
Association of oxLDL-lgG and oxLDL-lgM with AML
Table 4 shows that the odds ratios of association of
oxLDL-lgG and oxLDL-lgM with adult AML are 0.72
(95% CI = 0.55, 0.94) and 1.11(95% CI = 1.01, 1.21)
after adjusting for age, SBP, DBP, TC, HDL-c, and LDL-
c, respectively.
Discussion
The predominant isotype of oxLDL antibodies isolated
either from serum (free antibodies) or precipitated solu-
ble immune complexes (antigen-associated antibodies) is
IgG of subclasses 1 and 3 [7]. At present, oxLDL antibo-
dies have not yet become biomarkers for the develop-
ment and/or progression of atherosclerosis [8]. Positive
correlation between the levels of oxLDL-lgG antibodies
and different endpoints considered as evidence of
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many studies [9]. The protective role of IgM oxLDL
antibodies has been proposed in human cardiovascular
diseases [3].
In the present study, there were significantly lower
serum levels of TC, HDL-c, and ADP in the AML group
than that in the control group. The results were similar
to those of a previous research [1-3,5].
T h em a i nf i n d i n go ft h ep r e s e n ts t u d yw a st h ed e s -
censive oxLDL-lgG and elevated oxLDL-lgM serum
levels in patients with AML compared with normal
controls after controlled potential confounders by the
covariance analysis model. Logistic regression analysis
revealed that lower oxLDL-lgG serum levels predict
decreased risk of AML. However, higher oxLDL-lgM
serum levels predict increased risk of AML. In con-
trast, there were both elevated oxLDL-lgG and descen-
sive oxLDL-lgM serum levels in patients with
cardiovascular or cerebrovascular diseases in the
reported literature [3].
In recent years, there has been a growing body of evi-
dence that excessive lipid peroxidation, including oxLDL
and anti-oxLDL autoantibodies, which reflect in the
indicators of oxidative stress in vivo, may play a key role
in cancer development [9,10].
Table 1 Characteristics of the Subjects
Normal control
(n = 52)
Adult AML
(n = 43)
t-test p
Sex, male(%)
a 38.5 48.4 1.033 0.309
age 52.02 ± 12.269 42.72 ± 17.425 2.947 0.004
SBP mmHg 119.85 ± 12.432 125.12 ± 16.300 -1.742 0.085
DBP mmHg 78.17 ± 7.745 69.14 ± 12.1920 4.207 0.000
Albumin 45.75 ± 4.762 42.83 ± 6.729 2.455 0.017
TC mmol/L 5.50 ± 0.8123 4.01 ± 1.0569 7.796 0.000
TG mmol/L 1.42 ± 0.9356 1.65 ± 1.0770 -1.115 0.268
HDL-C mmol/L 1.22 ± 0.9280 0.62 ± 0.3982 4.192 0.000
LDL-C mmol/L 3.97 ± 1.1740 3.00 ± 1.0461 4.200 0.000
ADP ug/ml 4.21 ± 5.5410 7.56 ± 9.7684 -1.995 0.050
oxLDL ng/ml 34.74 ± 18.6549 31.34 ± 21.4124 0.882 0.413
oxLDL-IgG g/ml 78.88 ± 9.3705 38.92 ± 21.1259 11.486 0.000
oxLDL-IGM u/L 10.29 ± 10.5771 20.53 ± 10.2990 -4.756 0.000
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglyceride; HDL-c, High density lipoprotein-cholesterol; LDL-c,
Low density lipoprotein-cholesterol; ADP, adiponectin; oxLDL, oxidized low-density lipoprotein; oxLDL-lgG, immunoglobulin G type of autoantibodies to oxidized
low-density lipoprotein; oxLDL-lgM, immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein; AML, acute myeloblastic leukemia.
a: Pearson Chi-Square test.
Table 2 Influencing factors for oxLDL-lgG and oxLDL-lgM
Variables oxLDL-lgG oxLDL-lgM
sex 0.028 -0.027
age 0.172(**) -0.102(*)
SBP 0.157(**) -0.047
DBP 0.274(**) -0.114(*)
Albumin 0.151(*) -0,093
TC 0.308(**) -0.225(**)
TG -0.080 0.066
HDL-c 0.070 -0.105(*)
LDL-c 0.275(**) -0.196(**)
ADP -0.078 0.340(**)
OXLDL 0.104(*) -0.096
oxLDL-lgG 1.000 -0.244(**)
oxLDL-lgM -0.244(**) 1.000
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; TC,
total cholesterol; TG, triglyceride; HDL-c, High density lipoprotein-cholesterol;
LDL-c, Low density lipoprotein-cholesterol; ADP, adiponectin; oxLDL, oxidized
low-density lipoprotein; oxLDL-lgG, immunoglobulin G type of autoantibodies
to oxidized low-density lipoprotein; oxLDL-lgM, immunoglobulin M type of
autoantibodies to oxidized low-density lipoprotein; AML, acute myeloblastic
leukemia.
** Kendall’s correlation is significant at the 0.01 level (2-tailed).* Correlation is
significant at the 0.05 level (2-tailed).
Table 3 Estimated Marginal Means of oxLDL-lgG and oxLDL-lgM in Two Groups
AML controls
Mean ± SE Mean ± SE FP
oxLDL-lgG
a 42.991 ± 3.833 74.787 ± 3.245 11.795 0.000
oxLDL-lgM
b 18.724 ± 2.050 12.003 ± 1.722 9.858 0.000
a: Covariates appearing in the covariance model are evaluated at the following variables: gender, age, SBP, DBP, albumin, TC, TG, HDL-c, LDL-c, ADP, oxLDL, and
oxLDL-lgM.
b: Covariates appearing in the model are evaluated at the following variables: gender, age, SBP, DBP, albumin, TC, TG, HDL-c, LDL-c, ADP, oxLDL, and oxLDL-lgG.
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used as subjects. Lymphocytic leukemia and other blood
diseases were ruled out, and the misclassification error
does not exist. In the experimental determination of
indicators, less than 10% coefficient of variation was the
quality control. There were correlations between TC,
TG, HDL, and LDL, resulting in a collinearity in the lin-
ear regression analysis. Consequently, a covariance of
analysis was used in the study. Therefore, the results of
this study are not biased.
Conclusion
The present study shows that in contrast with the
detecting antibodies of oxLDL-lgG and oxLDL-lgM
serum levels in patients with cardiovascular and cere-
brovascular diseases in literature, the descensive oxLDL-
lgG and the elevated oxLDL-lgM serum levels may be
related to the development and progression of adult
AML. However, the findings are the results of a preli-
minary investigation. Many future studies are needed to
answer: what is a biological mechanism/relationship
behind the findings? Is IgG anti-oxLDL lower in patients
because it is complexes/bound to oxLDL? Is IgG anti-
oxLDL thought as a cause linkage with the development
of AML biology and leukemogenesis? How about the
relationship to other known risk factors for AML such
as smoking, exposure to certain chemicals etc? Is lipid
peroxidation and oxidative stress pronounced in AML?
Is there a relationship between anti-oxLDL and the
stage of the disease? After that the hypothesis of
whether oxLDL-lgG as well as oxLDL-lgM plays a cau-
sative or merely consequential role in AML can be veri-
fied, and in the interim, a novel strategy of prevention
and therapy for AML can be designated.
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Table 4 The association of oxLDL-lgG and oxLDL-lgM
with adult AML
OR 95%CI
a OR 95%CI
b
oxLDL-IgG
c 0.86 0.81-0.92 0.72 0.55-0.94
oxLDL-IGM
d 1.09 1.05-1.14 1.11 1.01-1.21
Abbreviations: SBP, systolic blood pressure;DBP, diastolic blood pressure;TC,
total cholesterol; HDL-c, High density lipoprotein-cholesterol; LDL-c, Low
density lipoprotein-cholesterol; ADP, adiponectin; oxLDL, oxidized low-density
lipoprotein; oxLDL-lgG, immunoglobulin G type of autoantibodies to oxidized
low-density lipoprotein; oxLDL-lgM, immunoglobulin M type of autoantibodies
to oxidized low-density lipoprotein; AML, acute myeloblastic leukemia; CI,
Confidence Interval.
a:unadjusted odds ratio;
b: adjusted odds ratio
c: adjusted by age, SBP, DBP, albumin, oxLDL, LDL-c;
d: adjusted by age, DBP, TC, ADP, HDL-c and LDL-c.
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